The findings of a large number of genome-wide association studies (GWAS) and clinical trials support the central role of TNF-IL-23-IL-17 signaling pathways in the pathogenesis of psoriasis, especially for plaque psoriasis.40–47. This evidence concerns the gene IL23A and psoriasis vulgaris.